Damita M 5/1000 Tablet ER
Marketer
Macleods Pharmaceuticals Pvt Ltd
Salt Composition
Dapagliflozin (5mg) + Metformin (1000mg)
Overview Damita M 5/1000 Tablet ER
DiabetaComb 5/1000 Extended-Release tablets combine two medications to manage type 2 diabetes. This dual-action formulation effectively regulates elevated blood glucose, mitigating the risk of severe diabetic complications and contributing to cardiovascular health. DiabetaComb 5/1000 ER can be taken with food, consistently at the same time each day for optimal adherence. Dosage is determined by your physician, and discontinuation should only occur under their guidance; abrupt cessation may lead to dangerously high blood sugar, increasing the risk of kidney disease and vision loss. This medication forms part of a comprehensive treatment plan incorporating a balanced diet, regular physical activity, and weight management as directed by your doctor. Commonly reported side effects include throat irritation, nasal stuffiness, rhinorrhea, cephalalgia, nausea, emesis, and diarrhea. Adequate hydration is recommended to minimize dehydration. Genital candidiasis may occur in some patients; meticulous hygiene is advised to reduce this risk. Prior to commencing treatment, discuss any pre-existing kidney or liver conditions, urinary tract infections, or diuretic use with your doctor. Pregnant or lactating individuals should seek medical consultation before using this medication. Limit alcohol consumption as it may intensify certain side effects. Regular blood glucose monitoring is essential during treatment.
Primary Ingredients of Damita M 5/1000 Tablet ER
No text was provided to rewrite.
Uses of Damita M 5/1000 Tablet ER
Managing type 2 diabetes
Major Benefits of Damita M 5/1000 Tablet ER:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the Damita M 5/1000 Tablet ER whole; avoid chewing, crushing, or fracturing it. Consumption should coincide with a meal.
Common Side effects of Damita M 5/1000 Tablet ER:
- Nausea
- Vomiting
- Diarrhea
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Polyuria
- Flatulence
- Skin rash
- Taste change
- Difficulty in urination
- Hypoglycemia (low blood glucose level)
- Tremors
- Dizziness
- Back pain
- Increased hematocrit
- Decreased creatinine clearance
- Dyslipidemia
How to use Damita M 5/1000 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Damita M 5/1000 Tablet ER whole; avoid crushing, chewing, or breaking it. Administer this extended-release tablet with a meal.
How Damita M 5/1000 Tablet ER works:
Damita M 5/1000 Extended-Release tablets contain dapagliflozin and metformin, two medications that manage blood glucose. Dapagliflozin facilitates glucose excretion via the kidneys, while metformin reduces hepatic glucose production, slows intestinal glucose uptake, and enhances insulin sensitivity. This dual action leads to superior glycemic control.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use and Damita M 5/1000 Tablet ER is strongly discouraged due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The extended-release Damita M 5/1000 Tablet may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a developing fetus. Prescribing will involve a physician's assessment of benefits versus potential hazards. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Damita M 5/1000 tablets are likely not safe for breastfeeding mothers. Available evidence from human studies indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if you experience these conditions.
KidneyCAUTION
For individuals with impaired kidney function, the extended-release Damita M 5/1000 Tablet requires careful administration. A modified dosage of Damita M 5/1000 Tablet ER might be necessary. Physician consultation is recommended.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Damita M 5/1000 Tablet ER. Dosage modification of Damita M 5/1000 Tablet ER may be necessary. Physician consultation is advised.
What if you forget to take Damita M 5/1000 Tablet ER :
Should you forget a Damita M 5/1000 Tablet ER, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Damita M 5/1000 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |


